Retinoid Differentiation Therapy for Common Types of Acute Myeloid Leukemia

Many cancers arise in a tissue stem cell, and cell differentiation is impaired resulting in an accumulation of immature cells. The introduction of all-trans retinoic acid (ATRA) in 1987 to treat acute promyelocytic leukemia (APL), a rare subtype of acute myeloid leukemia (AML), pioneered a new appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Geoffrey, Hughes, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504222/
https://www.ncbi.nlm.nih.gov/pubmed/23213553
http://dx.doi.org/10.1155/2012/939021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504222/
https://www.ncbi.nlm.nih.gov/pubmed/23213553
http://dx.doi.org/10.1155/2012/939021

Ejemplares similares